Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Endocrine-Related Cancer|January 30, 2007
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitorsMarissa V Powers, Paul WorkmanFEBS Letters|June 15, 2007
Inhibitors of the heat shock response: biology and pharmacologyMarissa V Powers, Paul WorkmanCancer Cell|September 6, 2008
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosisMarissa V Powers, Paul A Clarke, Paul WorkmanCell Cycle (Georgetown, Tex.)|February 7, 2009
Death by chaperone: HSP90, HSP70 or both?Marissa V Powers, Paul A Clarke, Paul WorkmanCell Cycle (Georgetown, Tex.)|April 8, 2010
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?Marissa V Powers, Keith Jones, Caterina Barillari, et al.Oncotarget|November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAXMarissa V Powers, Melanie Valenti, Susana Miranda, et al.NAR Cancer|March 16, 2026
Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cellsJennifer R Tall, Robert Te Poele, Alexandra Vasile, et al.Cancer Research|May 20, 2016
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer CellsRoberta Ferraldeschi, Jonathan Welti, Marissa V Powers, et al.Molecular Cancer Therapeutics|April 14, 2007
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analoguesSwee Y Sharp, Chrisostomos Prodromou, Kathy Boxall, et al.Nature Communications|February 27, 2025
Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E functionSwee Y Sharp, Marianna Martella, Sabrina D'Agostino, et al.Pageof 1